7don MSN
Structural blueprint for RNA therapeutics reveals why some siRNA molecules work better than others
RNA interference is a natural mechanism for living cells to control whether specific genes are being used. Crowned with the ...
AstraZeneca has added another piece to its sprawling interface with CSPC Pharmaceutical, paying the Chinese biotech $30 million upfront to jointly discover and develop two kidney disease drug ...
Live virtual fireside chat - investors, advisors, and life sciences analysts invited to attendKing of Prussia, Pennsylvania-- ...
RNA interference is a natural mechanism for living cells to control whether specific genes are being used or not.
Suzhou Ribo Life Science Co., Ltd. (06938.HK), and its subsidiary Ribocure Pharmaceuticals AB (collectively referred to as ...
The Chosun Ilbo on MSN
L’Oréal, OliX expand RNAi collaboration to nail care
Global beauty giant L’Oréal signed a contract on June 29 with domestic biotech firm OliX to discover “short interfering ...
11don MSN
Nanotech platform combining paclitaxel with siRNA boosts immune response against lung cancer
Researchers at the University of Arizona R. Ken Coit College of Pharmacy have developed a new strategy that helps the immune ...
Small interfering RNA (siRNA) drugs are a class of therapeutic agents that silence specific genes associated with inherited diseases. However, siRNA drugs have challenges because siRNAs often silence ...
The discovery of siRNA and its role in RNAi was a groundbreaking finding in the field of molecular biology. In 1998, Andrew Fire and Craig Mello published a seminal paper describing the phenomenon of ...
Two start-ups have launched to develop next-generation drugs using small interfering RNA (siRNA) to silence genes. The first, Judo Bio, is a spin-off of the venture capital firm Atlas Venture. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results